232 related articles for article (PubMed ID: 31347298)
1. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
[TBL] [Abstract][Full Text] [Related]
2. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
[TBL] [Abstract][Full Text] [Related]
3. Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients.
Freire BL; Homma TK; Funari MFA; Lerario AM; Leal AM; Velloso EDRP; Malaquias AC; Jorge AAL
Eur J Med Genet; 2018 Mar; 61(3):130-133. PubMed ID: 29133208
[TBL] [Abstract][Full Text] [Related]
4. A Case Report of Germline Compound Heterozygous Mutations in the
Kwong A; Ho CYS; Shin VY; Au CH; Chan TL; Ma ESK
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477375
[TBL] [Abstract][Full Text] [Related]
5. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
[TBL] [Abstract][Full Text] [Related]
6. Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice.
Park D; Bergin SM; Jones D; Ru P; Koivisto CS; Jeon YJ; Sizemore GM; Kladney RD; Hadjis A; Shakya R; Ludwig T
Cancer Res; 2020 Oct; 80(19):4172-4184. PubMed ID: 32732220
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia: causes and consequences of genetic instability.
Kalb R; Neveling K; Nanda I; Schindler D; Hoehn H
Genome Dyn; 2006; 1():218-242. PubMed ID: 18724063
[TBL] [Abstract][Full Text] [Related]
8. Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia.
Bogliolo M; Bluteau D; Lespinasse J; Pujol R; Vasquez N; d'Enghien CD; Stoppa-Lyonnet D; Leblanc T; Soulier J; Surrallés J
Genet Med; 2018 Apr; 20(4):458-463. PubMed ID: 28837157
[TBL] [Abstract][Full Text] [Related]
9. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.
Virts EL; Jankowska A; Mackay C; Glaas MF; Wiek C; Kelich SL; Lottmann N; Kennedy FM; Marchal C; Lehnert E; Scharf RE; Dufour C; Lanciotti M; Farruggia P; Santoro A; Savasan S; Scheckenbach K; Schipper J; Wagenmann M; Lewis T; Leffak M; Farlow JL; Foroud TM; Honisch E; Niederacher D; Chakraborty SC; Vance GH; Pruss D; Timms KM; Lanchbury JS; Alpi AF; Hanenberg H
Hum Mol Genet; 2015 Sep; 24(18):5093-108. PubMed ID: 26085575
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.
Spurdle AB; Whiley PJ; Thompson B; Feng B; Healey S; Brown MA; Pettigrew C; ; Van Asperen CJ; Ausems MG; Kattentidt-Mouravieva AA; van den Ouweland AM; ; Lindblom A; Pigg MH; Schmutzler RK; Engel C; Meindl A; ; Caputo S; Sinilnikova OM; Lidereau R; ; Couch FJ; Guidugli L; Hansen Tv; Thomassen M; Eccles DM; Tucker K; Benitez J; Domchek SM; Toland AE; Van Rensburg EJ; Wappenschmidt B; Borg Å; Vreeswijk MP; Goldgar DE;
J Med Genet; 2012 Aug; 49(8):525-32. PubMed ID: 22889855
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer and Fanconi anemia: what are the connections?
Zdzienicka MZ; Arwert F
Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.
de Garibay GR; Díaz A; Gaviña B; Romero A; Garre P; Vega A; Blanco A; Tosar A; Díez O; Pérez-Segura P; Díaz-Rubio E; Caldés T; de la Hoya M
Eur J Hum Genet; 2013 Aug; 21(8):883-6. PubMed ID: 23211700
[TBL] [Abstract][Full Text] [Related]
13. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics.
Bakker JL; Thirthagiri E; van Mil SE; Adank MA; Ikeda H; Verheul HM; Meijers-Heijboer H; de Winter JP; Sharan SK; Waisfisz Q
Hum Mutat; 2014 Apr; 35(4):442-6. PubMed ID: 24395671
[TBL] [Abstract][Full Text] [Related]
14. A Japanese patient with RAD51-associated Fanconi anemia.
Takenaka S; Kuroda Y; Ohta S; Mizuno Y; Hiwatari M; Miyatake S; Matsumoto N; Oka A
Am J Med Genet A; 2019 Jun; 179(6):900-902. PubMed ID: 30907510
[TBL] [Abstract][Full Text] [Related]
15. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
17. Biallelic variants in
Chirita-Emandi A; Andreescu N; Popa C; Mihailescu A; Riza AL; Plesea R; Ioana M; Arghirescu S; Puiu M
J Med Genet; 2021 Sep; 58(9):648-652. PubMed ID: 32843487
[TBL] [Abstract][Full Text] [Related]
18. The
Moghadasi S; Meeks HD; Vreeswijk MP; Janssen LA; Borg Å; Ehrencrona H; Paulsson-Karlsson Y; Wappenschmidt B; Engel C; Gehrig A; Arnold N; Hansen TVO; Thomassen M; Jensen UB; Kruse TA; Ejlertsen B; Gerdes AM; Pedersen IS; Caputo SM; Couch F; Hallberg EJ; van den Ouweland AM; Collée MJ; Teugels E; Adank MA; van der Luijt RB; Mensenkamp AR; Oosterwijk JC; Blok MJ; Janin N; Claes KB; Tucker K; Viassolo V; Toland AE; Eccles DE; Devilee P; Van Asperen CJ; Spurdle AB; Goldgar DE; García EG
J Med Genet; 2018 Jan; 55(1):15-20. PubMed ID: 28490613
[TBL] [Abstract][Full Text] [Related]
19. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Meindl A; Hellebrand H; Wiek C; Erven V; Wappenschmidt B; Niederacher D; Freund M; Lichtner P; Hartmann L; Schaal H; Ramser J; Honisch E; Kubisch C; Wichmann HE; Kast K; Deissler H; Engel C; Müller-Myhsok B; Neveling K; Kiechle M; Mathew CG; Schindler D; Schmutzler RK; Hanenberg H
Nat Genet; 2010 May; 42(5):410-4. PubMed ID: 20400964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]